GlassScriptPhysician profile
Scott M Parrotta
NPI 1487034500
$5,889.83
in general payments reported to CMS, 2019-2025
38 companies · $906 in 2025
The $906 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $138 · 2021: $944 · 2022: $1,392 · 2023: $1,224 · 2024: $1,285 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,141 · Consulting Fee: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,141.47 |
| Consulting Fee | $274.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,587.52 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $753.85 | 2021-2025 | |
| Sage Therapeutics, LLC | $350.00 | 2022 | |
| Novo Nordisk INC | $343.20 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $276.94 | 2020-2025 | Zepbound, Mounjaro, Kisunla |
| Ge Healthcare | $274.00 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $258.72 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $218.90 | 2021-2024 | Livalo, Seglentis, Zoryve |
| Abbott Laboratories | $212.93 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $177.04 | 2021-2024 | |
| Pfizer INC. | $176.13 | 2022-2025 | |
| Astellas Pharma US INC | $160.63 | 2020-2023 | Myrbetriq, Veozah |
| Glaxosmithkline, LLC. | $94.22 | 2021-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $85.54 | 2023-2024 | Cologuard Collection Kit |
| Ibsa Pharma INC. | $84.94 | 2020-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Parrotta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.